|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 265.30 DKK | +1.11% |
|
+4.74% | +22.01% |
| 09/06 | ISS loses UK healthcare contract - set to expire in Q3 | FW |
| 09/06 | ISS secures facility management contract with Upplands-Bro municipality | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 7.14TCr | 7.65TCr | 7.87TCr | 8.38TCr | 8.47TCr | |||||
Total Revenues | 7.14TCr | 7.65TCr | 7.87TCr | 8.38TCr | 8.47TCr | |||||
Cost of Goods Sold, Total | 502Cr | 659.8Cr | 748.1Cr | 751.9Cr | 717Cr | |||||
Gross Profit | 6.63TCr | 6.99TCr | 7.12TCr | 7.62TCr | 7.75TCr | |||||
Selling General & Admin Expenses, Total | 4.68TCr | 4.85TCr | 4.96TCr | 5.29TCr | 5.4TCr | |||||
Stock-Based Compensation (IS) | - | - | - | - | - | |||||
Depreciation & Amortization - (IS) | 176Cr | 151.7Cr | 141.7Cr | 146.9Cr | 155.5Cr | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 6.4Cr | 6.9Cr | 6.9Cr | 9.1Cr | 9.6Cr | |||||
Other Operating Expenses | 1.65TCr | 1.73TCr | 1.69TCr | 1.79TCr | 1.8TCr | |||||
Other Operating Expenses, Total | 6.51TCr | 6.73TCr | 6.81TCr | 7.23TCr | 7.36TCr | |||||
Operating Income | 120.2Cr | 262.5Cr | 313Cr | 394.3Cr | 392Cr | |||||
Interest Expense, Total | -46Cr | -40Cr | -58Cr | -74Cr | -74Cr | |||||
Interest And Investment Income | 4.1Cr | 6.9Cr | 9.8Cr | 22Cr | 18Cr | |||||
Net Interest Expenses | -42Cr | -34Cr | -48Cr | -53Cr | -56Cr | |||||
Currency Exchange Gains (Loss) | -5.1Cr | -4.9Cr | -10Cr | -2.3Cr | -2.6Cr | |||||
Other Non Operating Income (Expenses) | -8.2Cr | -12Cr | -9.1Cr | -9.4Cr | -7.4Cr | |||||
EBT, Excl. Unusual Items | 65Cr | 211.5Cr | 246Cr | 330Cr | 326.1Cr | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | -7.7Cr | -1.1Cr | -1.6Cr | -3.2Cr | -3.9Cr | |||||
Impairment of Goodwill | -45Cr | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 57Cr | 8.2Cr | -1.8Cr | -5.5Cr | -1Cr | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | 35Cr | 26Cr | 10Cr | 8.6Cr | 7.7Cr | |||||
EBT, Incl. Unusual Items | 104.5Cr | 244.6Cr | 253.1Cr | 329.9Cr | 328.9Cr | |||||
Income Tax Expense | 51Cr | 44Cr | 55Cr | 66Cr | 68Cr | |||||
Earnings From Continuing Operations | 54Cr | 200.5Cr | 197.7Cr | 264.1Cr | 261.3Cr | |||||
Earnings Of Discontinued Operations | 10Cr | 13Cr | -165.2Cr | -5.2Cr | - | |||||
Net Income to Company | 64Cr | 213.6Cr | 32Cr | 258.9Cr | 261.3Cr | |||||
Minority Interest | -2.2Cr | -7.8Cr | -4.6Cr | -80L | -1Cr | |||||
Net Income - (IS) | 62Cr | 205.8Cr | 28Cr | 258.1Cr | 260.3Cr | |||||
Net Income to Common Incl Extra Items | 62Cr | 205.8Cr | 28Cr | 258.1Cr | 260.3Cr | |||||
Net Income to Common Excl. Extra Items | 51Cr | 192.7Cr | 193.1Cr | 263.3Cr | 260.3Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.33 | 11.14 | 1.51 | 14.26 | 15.56 | |||||
Basic EPS - Continuing Operations | 2.78 | 10.43 | 10.42 | 14.55 | 15.56 | |||||
Basic Weighted Average Shares Outstanding | 18Cr | 18Cr | 19Cr | 18Cr | 17Cr | |||||
Net EPS - Diluted | 3.33 | 11 | 1.51 | 14.12 | 15.4 | |||||
Diluted EPS - Continuing Operations | 2.78 | 10.3 | 10.3 | 14.4 | 15.4 | |||||
Diluted Weighted Average Shares Outstanding | 19Cr | 19Cr | 19Cr | 18Cr | 17Cr | |||||
Normalized Basic EPS | 2.09 | 6.73 | 8.05 | 11.35 | 12.12 | |||||
Normalized Diluted EPS | 2.08 | 6.64 | 7.94 | 11.2 | 12.01 | |||||
Dividend Per Share | - | 2.1 | 2.3 | 3.1 | 3.2 | |||||
Payout Ratio | - | - | 139.78 | 16.47 | 20.51 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 181.5Cr | 311.6Cr | 353.7Cr | 436.3Cr | 436.2Cr | |||||
EBITA | 126.6Cr | 269.4Cr | 319Cr | 403.4Cr | 401.6Cr | |||||
EBIT | 120.2Cr | 262.5Cr | 313Cr | 394.3Cr | 392Cr | |||||
EBITDAR | 208.4Cr | 341.8Cr | 373.1Cr | 459.5Cr | 457.3Cr | |||||
Effective Tax Rate - (Ratio) | 48.71 | 18.03 | 21.89 | 19.95 | 20.55 | |||||
Total Current Taxes | 49Cr | 54Cr | 49Cr | 66Cr | 67Cr | |||||
Total Deferred Taxes | 4.6Cr | -8.9Cr | 6.6Cr | 5.9Cr | 6.4Cr | |||||
Normalized Net Income | 39Cr | 124.39Cr | 149.15Cr | 205.45Cr | 202.81Cr | |||||
Interest on Long-Term Debt | 16Cr | 8.2Cr | 15Cr | 18Cr | 18Cr | |||||
Non-Cash Pension Expense | 4.9Cr | 2.8Cr | 4.2Cr | 3.1Cr | 8.3Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Net Rental Expense, Total | 27Cr | 30Cr | 19Cr | 23Cr | 21Cr | |||||
Imputed Operating Lease Interest Expense | 5.52Cr | 5.77Cr | 5.34Cr | 7.86Cr | 7.48Cr | |||||
Imputed Operating Lease Depreciation | 21Cr | 24Cr | 14Cr | 15Cr | 14Cr | |||||
Stock-Based Comp., Other (Total) | 6.2Cr | 8Cr | 7.2Cr | 9.3Cr | 9.3Cr | |||||
Total Stock-Based Compensation | 6.2Cr | 8Cr | 7.2Cr | 9.3Cr | 9.3Cr |
- Stock Market
- Stocks
- ISS Stock
- Financials ISS A/S
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















